Barclays’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-359
Closed 4512
2022
Q4
$0 Sell
359
-13,293
-97% ﹤0.01% 4618
2022
Q3
$16K Sell
13,652
-1,033
-7% -$1.21K ﹤0.01% 4030
2022
Q2
$9K Sell
14,685
-14,246
-49% -$8.73K ﹤0.01% 4366
2022
Q1
$34K Sell
28,931
-92,037
-76% -$108K ﹤0.01% 4151
2021
Q4
$272K Buy
120,968
+70,475
+140% +$158K ﹤0.01% 2741
2021
Q3
$172K Buy
50,493
+24,666
+96% +$84K ﹤0.01% 3040
2021
Q2
$78K Buy
25,827
+16,610
+180% +$50.2K ﹤0.01% 3223
2021
Q1
$30K Buy
+9,217
New +$30K ﹤0.01% 3600
2020
Q3
Sell
-1
Closed 3988
2020
Q2
$0 Buy
+1
New ﹤0.01% 4018
2019
Q2
Sell
-96
Closed 4505
2019
Q1
$0 Hold
96
﹤0.01% 4471
2018
Q4
$0 Hold
96
﹤0.01% 4484
2018
Q3
$0 Hold
96
﹤0.01% 4531
2018
Q2
$0 Sell
96
-15,011
-99% ﹤0.01% 4454
2018
Q1
$32K Sell
15,107
-31,389
-68% -$66.5K ﹤0.01% 3700
2017
Q4
$94K Buy
46,496
+45,400
+4,142% +$91.8K ﹤0.01% 3036
2017
Q3
$1K Sell
1,096
-33,261
-97% -$30.3K ﹤0.01% 3964
2017
Q2
$54K Buy
34,357
+15,322
+80% +$24.1K ﹤0.01% 2993
2017
Q1
$61K Buy
19,035
+8,701
+84% +$27.9K ﹤0.01% 3031
2016
Q4
$13K Buy
10,334
+8,421
+440% +$10.6K ﹤0.01% 3215
2016
Q3
$3K Sell
1,913
-13,071
-87% -$20.5K ﹤0.01% 3542
2016
Q2
$20K Buy
14,984
+14,682
+4,862% +$19.6K ﹤0.01% 2819
2016
Q1
$1K Sell
302
-772
-72% -$2.56K ﹤0.01% 3358
2015
Q4
$8K Sell
1,074
-34,246
-97% -$255K ﹤0.01% 2850
2015
Q3
$282K Buy
35,320
+24,347
+222% +$194K ﹤0.01% 1978
2015
Q2
$109K Buy
10,973
+8,682
+379% +$86.2K ﹤0.01% 2322
2015
Q1
$29K Sell
2,291
-6,950
-75% -$88K ﹤0.01% 2975
2014
Q4
$148K Sell
9,241
-296,725
-97% -$4.75M ﹤0.01% 2499
2014
Q3
$3.98M Buy
305,966
+75,435
+33% +$981K ﹤0.01% 1062
2014
Q2
$2.77M Buy
230,531
+6,660
+3% +$79.9K ﹤0.01% 1225
2014
Q1
$2.46M Buy
223,871
+44,157
+25% +$486K ﹤0.01% 1242
2013
Q4
$2.34M Buy
179,714
+5,661
+3% +$73.6K ﹤0.01% 1321
2013
Q3
$2.96M Sell
174,053
-56,789
-25% -$965K ﹤0.01% 1093
2013
Q2
$3.74M Buy
+230,842
New +$3.74M ﹤0.01% 977